Cargando…
Interventional Treatment for Cholangiocarcinoma
Cholangiocarcinoma (CCA) is the second most common type of primary liver malignancy. The latest classification includes intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma, with the latter one further categorized into perihilar and distal cholangiocarcinoma. Although surgical resecti...
Autores principales: | Li, Hang, Chen, Li, Zhu, Guang-Yu, Yao, Xijuan, Dong, Rui, Guo, Jin-He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276166/ https://www.ncbi.nlm.nih.gov/pubmed/34268114 http://dx.doi.org/10.3389/fonc.2021.671327 |
Ejemplares similares
-
Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of Metformin Treatment on Cholangiocarcinoma Cells
por: Zhang, Jin, et al.
Publicado: (2020) -
A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma
por: Qian, Xianling, et al.
Publicado: (2022) -
Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma
por: Pan, Yan, et al.
Publicado: (2022) -
Differences in Clinical Features and Diagnostic Strategies Between IgG4-Related Autoimmune Cholangitis and Cholangiocarcinoma
por: Zhu, Ke, et al.
Publicado: (2021) -
Association of systemic inflammation index with survival in patients with advanced perihilar cholangiocarcinoma treated with interventional therapy
por: Li, Jinyu, et al.
Publicado: (2022)